Reading Time: 4 minutesThe top-line results from the Cytokinetics Inc Phase IIb clinical trial of Tirasemtiv were announced last week. Following this announcement, detailed results were then presented
Year: 2014
Reading Time: 2 minutesA lot has been happening in terms of research policy at the moment, from the announcement of the European adaptive licensing pilot to the Government’s Early Access to
Reading Time: 4 minutesThe day finally arrived on 11 April 2014 for our biannual Biomedical Research Advisory Panel (BRAP) Meeting. This important date in our research calendar is
Reading Time: 4 minutesDr Jakub Scaber from the University of Oxford is our newest Medical Research Council (MRC)/ MND Association Lady Edith Wolfson Clinical Research Fellow. He is investigating
Reading Time: 4 minutesLast month the UK Government’s Department of Health announced an Early Access to Medicines Scheme. But, what is this new scheme? and what does it
Reading Time: 3 minutesProf Vladimir Buchman (Cardiff University)’s research was selected as one of the best research studies, as decided by the journal editors, published in the Journal
Reading Time: 4 minutesMND Association-funded researcher, Prof Linda Greensmith, based at University College London, together with her collaborator Dr Ivo Lieberam from Kings College London, have introduced stem
Reading Time: 4 minutesFollowing on from our ’year of hope’ appeal last month an international team of researchers, including two funded by the MND Association, have identified mutations
Reading Time: 3 minutesOn 3 March 2014, researchers based at the University of Edinburgh published a research paper that extends our understanding of the childhood disease – Spinal
Causes and disease mechanisms Get involved with research MND Research Models of MND Research we fund
Flying towards understanding: MND, TDP43, flies and a competition
Reading Time: 3 minutesThe MND Association has funded a number of research projects in the laboratory of Dr Frank Hirth at the Institute of Psychiatry, King’s College London.